HB1032 HD1 HMSO Page2 H.B
Total Page:16
File Type:pdf, Size:1020Kb
HOUSE OF REPRESENTATIVES ~ 1032 THIRTY-FIRST LEGISLATURE, 2021 IN H.D. I STATE OF HAWAII a A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 1 SECTION 1. Section 329—14, Hawaii Revised Statutes, is 2 amended as follows: 3 1. By amending subsection (b) to read: 4 “(b) Any of the following opiates, including their 5 isomers, esters, ethers, salts, and salts of isomers, esters, 6 and ethers, unless specifically excepted, whenever the existence 7 of these isomers, esters, ethers, and salts is possible within 8 the specific chemical designation: 9 (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- 10 phenethyl) —4-piperidinyl] -N-phenylacetamide); 11 (2) Acetylmethadol; 12 (3) Allyiprodine; 13 (4) Aiphacetylmethadol (except levo-alphacetylmethadol, 14 levomethadyl acetate, or LAAM); 15 (5) Aiphameprodine; 16 (6) Aiphamethadol; 2021—2263 HB1032 HD1 HMSO Page2 H.B. NCD. ~g~1 1 (7) Aipha-methylfentanyl (N- [1- (alpha-methyl-beta- 2 phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl- 3 2-phenylethyl)-4-(N-propanilido) piperidine); 4 (8) Alpha-methylthiofentanyl (N—[1-methyl-2-(2- 5 thienyl) ethyl—4-piperidinyl] -N-phenylpropanamide); 6 (9) Benzethidine; 7 (10) Betacetylmethadol; 8 (11) Beta-hydroxyfentanyl (N- [1- (2-hydroxy-2-phenethyl) -4- 9 piperidinyl] -N-phenylpropanamide); 10 (12) Beta-hydroxy-3-methylfentariyl (N-[1-(2-hydroxy-2- 11 phenethyl) -3-methyl-4-piperidinyl] -N- 12 phenyipropanamide); 13 (13) Betameprodine; 14 (14) Betamethadol; 15 (15) Betaprodine; 16 (16) Clonitazene; 17 (17) Dextromoramide; 18 (18) Diampromide; 19 (19) Diethyithiambutene; 20 (20) Difenoxin; 21 (21) Dimenoxadol; 2021—2263 HB1032 HD1 HMSO 2 H.B. NO. ~ 1 (22) Dimepheptanol; 2 (23) Dimethyithiambutene; 3 (24) Dioxaphetyl butyrate; 4 (25) Dipipanone; 5 (26) Ethylmethyithiambutene; 6 (27) Etonitazene; 7 (28) Etoxeridine; 8 (29) Furethidine; 9 (30) Hydroxypethidine; 10 (31) Ketobemidone; 11 (32) Levomoramide; 12 (33) Levophenacylmorphan; 13 (34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- 14 piperidyl] -N-phenylpropanamide); 15 (35) 3-methyithiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl- 16 4-piperidinyl] -N-phenylpropanamide); 17 (36) Morpheridine; 18 (37) MPPP (1-methyl-4-phenyl-4--propionoxypiperidine); 19 (38) Noracymethadol; 20 (39) Norlevorphanol; 21 (40) Normethadone; 2021—2263 HB1032 HD1 HMSO 3 H.B. NO. ~ 1 (41) Norpipanone; 2 (42) Para—fluorofentanyl (N—(4—fluorophenyl)-N—[1-(2- 3 phenethyl) —4-piperidinyl] propanamide; 4 (43) PEPAP (1-(—2-phenethyl)-4-phenyl-4-acetoxypiperidine; 5 (44) Phenadoxone; 6 (45) Phenampromide; 7 (46) Phenomorphan; 8 (47) Phenoperidine; 9 (48) Piritramide; 10 (49) Proheptazine; 11 (50) Properidine; 12 (51) Propiram; 13 (52) Racemoramide; 14 (53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4- 15 piperidinyl] -propanamide); 16 (54) Tilidine; 17 (55) Trimeperidine; 18 (56) N- (1-benzyl-4-piperidyl] -N-phenylpropanamide 19 (benzylfentanyl), its optical isomers, salts, and 20 salts of isomers; 2021—2263 HB1032 HD1 HMSO 4 Page5 H.B. NC). ~ 1 (57) N—[l—(2—thienyl)methyl—4—piperidyl]—N— 2 phenyipropanamide (thenylfentanyl), its optical 3 isomers, salts, and salts of isomers; 4 (58) N-(l-phenethylpiperidin-4-yl)-N-phenylacetamide, 5 (acetyl fentanyl), its optical, positional, and 6 geometric isomers, salts, and salts of isomers; 7 (59) AH—792l (3,4—dichloro—N—[(1—dimethylamino) 8 cyclohexylmethyl]benzamide), its isomers, esters, 9 ethers, salts, and salts of isomers, esters, and 10 ethers; 11 (60) N-(l-phenethylpiperidin-4-yl)-N-phenylbutyramide, its 12 isomers, esters, ethers, salts, and salts of isomers, 13 esters, and ethers (Other names: Butyryl fentanyl); 14 (61) N—[l—[2—hydroxy—2-(thiophen—2-yl)ethyl]piperidin—4- 15 yl]—N—phenylpropionamide, its isomers, esters, ethers, 16 salts, and salts of isomers, esters, and ethers (Other 17 names: beta-hydroxythiofentanyl); 18 (62) N—(l—phenethylpiperidin-4—yl)—N-phenvlfuran—2- 19 carboxamide, its isomers, esters, ethers, salts, and 20 salts of isomers, esters, and ethers (Other names: 21 Furanyl fentanyl); 2021—2263 HB1O32 HD1 HMSO 5 H.B. NCD. ~ 1 (63) 3,4-dichloro—N—[2—(dimethylamino)cvclohexyl]-N- 2 methvlbenzamide, its isomers, esters, ethers, salts, 3 and salts of isomers, esters, and ethers (Other names: 4 U—47700) 5 (64) 4—fluoroisobutyryl fentanyl or para-fluoroisobutyryl 6 [fcnranyl] fentanyl [N-(4-fluorophenyl)-N-(1- 7 phenethylpiperidin-4-yl) isobutyramide]; 8 (65) Acryl fentanyl or acryloylfentanyl [N—(1— 9 phenethylpiperidin-4-yl) -N-phenylacrylamide]; La-~] 10 (66) Ocfentanil [[N (2 fluorophcnyl)—2-mcthoxy-N—(l— 11 phcncthylpiprtidin 4 yl)acctamidc] .1 [N—(2- 12 fluorophenyl) —2-methoxy-N- (l-phenethylpiperidin-4- 13 yl)acetamide]; 14 (67) Cyclopropyl fentanyl (N-(l-phenethylpiperidin-4-yl)-N- 15 phenylcyclopropanecarboxamide; 16 (68) Methoxyacetyl fentanyl (2-methoxy-N-(1- 17 phenethylpiperidin-4-yl) —N-phenylacetamide); 18 (69) Ortho—fluorofentanyl (N—(2-fluorophenyl)—N-(1- 19 phenethylpiperidin-4-yl)propionamide) (Other name: 2- 20 fluorofentanyl); and 2021—2263 HB1032 HD1 HMSO 6 H.B. NED. ~i 1 (70) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(l- 2 phenethylpiperidin-4-yl) butyramide) •uI 3 2. By amending subsection Ce) to read: 4 “Ce) Depressants. Unless specifically excepted, the 5 schedule shall include any material, compound, mixture, or 6 preparation which contains any quantity of the substance: 7 (1) Mecloqualone; [e~] 8 (2) Methaqualone[--]; 9 (3) Etizolam (including its optical, positional, and 10 geometric isomers, salts, and salts of isomers, where 11 possible) ; or 12 (4) Flualprazolam (including its optical, positional, and 13 geometric isomers, salts, and salts of isomers, where 14 possible) .“ 15 3. By amending subsection (g) to read: 16 “(g) Any of the following cannabinoids, their salts, 17 isomers, and salts of isomers, unless specifically excepted, 18 whenever the existence of these salts, isomers, and salts of 19 isomers is possible within the specific chemical designation: 20 (1) Tetrahydrocannabinols; meaning tetrahydrocannabinols 21 naturally contained in a plant of the genus Cannabis 2021—2263 HB1032 HD1 HMSO 7 H.B. NO. ~ 1 (cannabis plant), as well as synthetic equivalents of 2 the substances contained in the plant, or in the 3 resinous extractives of Cannabis, sp. or synthetic 4 substances, derivatives, and their isomers with 5 similar chemical structure and pharmacological 6 activity to those substances contained in the plant, 7 such as the following: Delta 1 cis or trans 8 tetrahydrocannabinol, and their optical isomers; Delta 9 6 cis or trans tetrahydrocannabinol, and their optical 10 isomers; and Delta 3,4 cis or trans 11 tetrahydrocannabinol, and its optical isomers (since 12 nomenclature of these substances is not 13 internationally standardized, compounds of these 14 structures, regardless of numerical designation of 15 atomic positions, are covered) ; 16 (2) Naphthoylindoles; meaning any compound containing a 3- 17 (1—naphthoyl)indole structure with substitution at the 18 nitrogen atom of the indole ring by a alkyl, 19 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 20 1-(N-methyl-2-piperidinyl)methyl or 2-(4- 21 morpholinyl)ethyl group, whether or not further 2021—2263 HB1032 HD1 HMSO 8 H.B. NcD. ~ 1 substituted in the indole ring to any extent and 2 whether or not substituted in the naphthyl ring to any 3 extent; 4 (3) Naphthylmethylindoles; meaning any compound containing 5 a 1H-indol-3-yl-(l-naphthyl) methane structure with 6 substitution at the nitrogen atom of the indole ring 7 by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 8 cycloalkylethyl, l-(N-methyl-2-piperidinyl) methyl or 9 2-(4-morpholinyl) ethyl group whether or not further 10 substituted in the indole ring to any extent and 11 whether or not substituted in the naphthyl ring to any 12 extent; 13 (4) Naphthoylpyrroles; meaning any compound containing a 14 3-(l-naphthoyl)pyrrole structure with substitution at 15 the nitrogen atom of the pyrrole ring by a alkyl, 16 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 17 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl) 18 ethyl group whether or not further substituted in the 19 pyrrole ring to any extent, whether or not substituted 20 in the naphthyl ring to any extent; 2021—2263 HB1032 HD1 HMSO 9 H.B. NCD. ~ 1 (5) Naphthylmethylindenes; meaning any compound containing 2 a naphthylideneindene structure with substitution at 3 the 3-position of the indene ring by a alkyl, 4 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 5 l—(N—methyl—2—piperidinyl) methyl or 2—(4—morpholinyl) 6 ethyl group whether or not further substituted in the 7 indene ring to any extent, whether or not substituted 8 in the naphthyl ring to any extent; 9 (6) Phenylacetylindoles; meaning any compound containing a 10 3—phenylacetylindole structure with substitution at 11 the nitrogen atom of the indole ring by a alkyl, 12 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 13 l—(N—methyl—2—piperidinyl) methyl or 2—(4-morpholinyl) 14 ethyl group whether or not further substituted in the 15 indole ring to any extent, whether or not substituted 16 in the phenyl ring to any extent; 17 (7) Cyclohexyiphenols; meaning any compound containing a 18 2-(3-hydroxycyclohexyl) phenol structure with 19 substitution at the 5-position of the phenolic ring by 20 a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 21 cycloalkylethyl, l-(N-methyl-2-piperidinyl) methyl or 2021—2263 HB1032 HD1 HMSO H.B. NcD. ~ 1 2-(4-morpholinyl) ethyl group whether or not 2